Skip to main content
Top

Open Access 25-04-2024 | Hypertension | Nutrition and Hypertension (T Mori, Section Editor)

Breaking the Barrier: The Role of Gut Epithelial Permeability in the Pathogenesis of Hypertension

Authors: Matthew Snelson, Tim Vanuytsel, Francine Z. Marques

Published in: Current Hypertension Reports

Login to get access

Abstract

Purpose of the Review

To review what intestinal permeability is and how it is measured, and to summarise the current evidence linking altered intestinal permeability with the development of hypertension.

Recent Findings

Increased gastrointestinal permeability, directly measured in vivo, has been demonstrated in experimental and genetic animal models of hypertension. This is consistent with the passage of microbial substances to the systemic circulation and the activation of inflammatory pathways. Evidence for increased gut permeability in human hypertension has been reliant of a handful of blood biomarkers, with no studies directly measuring gut permeability in hypertensive cohorts. There is emerging literature that some of these putative biomarkers may not accurately reflect permeability of the gastrointestinal tract.

Summary

Data from animal models of hypertension support they have increased gut permeability; however, there is a dearth of conclusive evidence in humans. Future studies are needed that directly measure intestinal permeability in people with hypertension.
Literature
18.
19.
go back to reference •• Horowitz A, Chanez-Paredes SD, Haest X, Turner JR. Paracellular permeability and tight junction regulation in gut health and disease. Nat Rev Gastroenterol Hepatol. 2023;20(7):417–32. https://doi.org/10.1038/s41575-023-00766-3. This review provides in-depth details of the molecular mechanisms by which paracellular permeability is regulated, with relevance to disease conditions of the gastrointestinal tract.CrossRefPubMed •• Horowitz A, Chanez-Paredes SD, Haest X, Turner JR. Paracellular permeability and tight junction regulation in gut health and disease. Nat Rev Gastroenterol Hepatol. 2023;20(7):417–32. https://​doi.​org/​10.​1038/​s41575-023-00766-3. This review provides in-depth details of the molecular mechanisms by which paracellular permeability is regulated, with relevance to disease conditions of the gastrointestinal tract.CrossRefPubMed
35.
go back to reference Graham WV, Wang F, Clayburgh DR, Cheng JX, Yoon B, Wang Y, et al. Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter. J Biol Chem. 2006;281(36):26205–15. https://doi.org/10.1074/jbc.M602164200.CrossRefPubMed Graham WV, Wang F, Clayburgh DR, Cheng JX, Yoon B, Wang Y, et al. Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter. J Biol Chem. 2006;281(36):26205–15. https://​doi.​org/​10.​1074/​jbc.​M602164200.CrossRefPubMed
48.
go back to reference Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clinical science (London, England : 1979). 2018;132(6):701–18. https://doi.org/10.1042/cs20180087. Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clinical science (London, England : 1979). 2018;132(6):701–18. https://​doi.​org/​10.​1042/​cs20180087.
53.
go back to reference Ainsworth M, Eriksen J, Rasmussen JW, Schaffalitzky de Muckadell OB. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol. 1989;24(8):993–8. https://doi.org/10.3109/00365528909089246. Ainsworth M, Eriksen J, Rasmussen JW, Schaffalitzky de Muckadell OB. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol. 1989;24(8):993–8. https://​doi.​org/​10.​3109/​0036552890908924​6.
60.
go back to reference Wilms E, Jonkers D, Savelkoul HFJ, Elizalde M, Tischmann L, de Vos P, et al. The Impact of Pectin Supplementation on Intestinal Barrier Function in Healthy Young Adults and Healthy Elderly. Nutrients. 2019;11(7). https://doi.org/10.3390/nu11071554. Wilms E, Jonkers D, Savelkoul HFJ, Elizalde M, Tischmann L, de Vos P, et al. The Impact of Pectin Supplementation on Intestinal Barrier Function in Healthy Young Adults and Healthy Elderly. Nutrients. 2019;11(7). https://​doi.​org/​10.​3390/​nu11071554.
66.
go back to reference Tatucu-Babet OA, Forsyth A, Udy A, Radcliffe J, Benheim D, Calkin C, et al. Use of a sensitive multisugar test for measuring segmental intestinal permeability in critically ill, mechanically ventilated adults: A pilot study. JPEN J Parenter Enteral Nutr. 2022;46(2):454–61. https://doi.org/10.1002/jpen.2110.CrossRefPubMed Tatucu-Babet OA, Forsyth A, Udy A, Radcliffe J, Benheim D, Calkin C, et al. Use of a sensitive multisugar test for measuring segmental intestinal permeability in critically ill, mechanically ventilated adults: A pilot study. JPEN J Parenter Enteral Nutr. 2022;46(2):454–61. https://​doi.​org/​10.​1002/​jpen.​2110.CrossRefPubMed
67.
go back to reference Cao S, Shaw EL, Quarles WR, Sasaki GY, Dey P, Hodges JK et al. Daily Inclusion of Resistant Starch-Containing Potatoes in a Dietary Guidelines for Americans Dietary Pattern Does Not Adversely Affect Cardiometabolic Risk or Intestinal Permeability in Adults with Metabolic Syndrome: A Randomized Controlled Trial. Nutrients. 2022;14(8). https://doi.org/10.3390/nu14081545. Cao S, Shaw EL, Quarles WR, Sasaki GY, Dey P, Hodges JK et al. Daily Inclusion of Resistant Starch-Containing Potatoes in a Dietary Guidelines for Americans Dietary Pattern Does Not Adversely Affect Cardiometabolic Risk or Intestinal Permeability in Adults with Metabolic Syndrome: A Randomized Controlled Trial. Nutrients. 2022;14(8). https://​doi.​org/​10.​3390/​nu14081545.
85.
go back to reference Zhou S, Xu C-D, Chen S-N, Liu W. [Correlation of intestinal mucosal injury with serum diamine oxidase]. Zhonghua Er Ke Za Zhi. 2006;44(2):93–5. Zhou S, Xu C-D, Chen S-N, Liu W. [Correlation of intestinal mucosal injury with serum diamine oxidase]. Zhonghua Er Ke Za Zhi. 2006;44(2):93–5.
91.
go back to reference Tan Z, Ou Y, Cai W, Zheng Y, Li H, Mao Y, et al. Advances in the Clinical Application of Histamine and Diamine Oxidase (DAO) Activity: A Review. Catalysts. 2023;13(1):48.CrossRef Tan Z, Ou Y, Cai W, Zheng Y, Li H, Mao Y, et al. Advances in the Clinical Application of Histamine and Diamine Oxidase (DAO) Activity: A Review. Catalysts. 2023;13(1):48.CrossRef
97.
go back to reference Robles-Vera I, de la Visitación N, Sánchez M, Gómez-Guzmán M, Jiménez R, Moleón J, et al. Mycophenolate Improves Brain-Gut Axis Inducing Remodeling of Gut Microbiota in DOCA-Salt Hypertensive Rats. Antioxidants (Basel). 2020;9(12). https://doi.org/10.3390/antiox9121199. Robles-Vera I, de la Visitación N, Sánchez M, Gómez-Guzmán M, Jiménez R, Moleón J, et al. Mycophenolate Improves Brain-Gut Axis Inducing Remodeling of Gut Microbiota in DOCA-Salt Hypertensive Rats. Antioxidants (Basel). 2020;9(12). https://​doi.​org/​10.​3390/​antiox9121199.
98.
go back to reference Ntlahla EE, Mfengu MM, Engwa GA, Nkeh-Chungag BN, Sewani-Rusike CR. Gut permeability is associated with hypertension and measures of obesity but not with Endothelial Dysfunction in South African youth. Afr Health Sci. 2021;21(3):1172–84.CrossRefPubMedPubMedCentral Ntlahla EE, Mfengu MM, Engwa GA, Nkeh-Chungag BN, Sewani-Rusike CR. Gut permeability is associated with hypertension and measures of obesity but not with Endothelial Dysfunction in South African youth. Afr Health Sci. 2021;21(3):1172–84.CrossRefPubMedPubMedCentral
100.
go back to reference Tomsett KI, Barrett HL, Dekker EE, Callaway LK, McIntyre DH, Dekker NM. Dietary Fiber Intake Alters Gut Microbiota Composition but Does Not Improve Gut Wall Barrier Function in Women with Future Hypertensive Disorders of Pregnancy. Nutrients. 2020;12(12):3862.CrossRefPubMedPubMedCentral Tomsett KI, Barrett HL, Dekker EE, Callaway LK, McIntyre DH, Dekker NM. Dietary Fiber Intake Alters Gut Microbiota Composition but Does Not Improve Gut Wall Barrier Function in Women with Future Hypertensive Disorders of Pregnancy. Nutrients. 2020;12(12):3862.CrossRefPubMedPubMedCentral
103.
go back to reference • Vemuri R, Ruggiero A, Whitfield JM, Dugan GO, Cline JM, Block MR, et al. Hypertension promotes microbial translocation and dysbiotic shifts in the fecal microbiome of nonhuman primates. Am J Physiol Heart Circ Physiol. 2022;322(3):H474–85. https://doi.org/10.1152/ajpheart.00530.2021. This study in non-human primates provides longitudinal evidence over 2 years that intestinal permeability progressively increases in the context of hypertension.CrossRefPubMedPubMedCentral • Vemuri R, Ruggiero A, Whitfield JM, Dugan GO, Cline JM, Block MR, et al. Hypertension promotes microbial translocation and dysbiotic shifts in the fecal microbiome of nonhuman primates. Am J Physiol Heart Circ Physiol. 2022;322(3):H474–85. https://​doi.​org/​10.​1152/​ajpheart.​00530.​2021. This study in non-human primates provides longitudinal evidence over 2 years that intestinal permeability progressively increases in the context of hypertension.CrossRefPubMedPubMedCentral
Metadata
Title
Breaking the Barrier: The Role of Gut Epithelial Permeability in the Pathogenesis of Hypertension
Authors
Matthew Snelson
Tim Vanuytsel
Francine Z. Marques
Publication date
25-04-2024
Publisher
Springer US
Published in
Current Hypertension Reports
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-024-01307-2
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare